|
關(guān)注:1
2013-05-23 12:21
求翻譯:在基本處方的基礎(chǔ)上,對(duì)影響吡非尼酮脂質(zhì)體包封率、粒徑大小和粒徑分布等因素進(jìn)行單因素考察,選擇4個(gè)主要因素進(jìn)行正交設(shè)計(jì)研究,得到優(yōu)化的處方和制備工藝。是什么意思?![]() ![]() 在基本處方的基礎(chǔ)上,對(duì)影響吡非尼酮脂質(zhì)體包封率、粒徑大小和粒徑分布等因素進(jìn)行單因素考察,選擇4個(gè)主要因素進(jìn)行正交設(shè)計(jì)研究,得到優(yōu)化的處方和制備工藝。
問題補(bǔ)充: |
|
2013-05-23 12:21:38
Single factor, the impact of topiramate non-Nepalese ketone liposome encapsulation efficiency, particle size and particle size distribution and other factors on the basis of the basic prescription, select the four main factors orthogonal design, optimized prescription and preparation process.
|
|
2013-05-23 12:23:18
In the basic recipe, on the basis of the affected joint, methadone liposomes encapsulating rate, particle size, such as size and particle size distribution with a single factor, factor 4 of the main factors in orthogonal design research, optimization of the prescription and the preparation process.
|
|
2013-05-23 12:24:58
In the basic prescription foundation, to affects, particle size size and grain-size distribution factors and so on the pyrrole non-Nepal alkone lipin body envelope rate carries on the single factor inspection, chooses 4 primary factors to conduct the orthogonal design research, obtains the optimized
|
|
2013-05-23 12:26:38
Basic prescription on the basis of, on the effect of non-effect of liposome entrapment, such factors as particle size and particle size distribution for single factors, select the orthogonal design study 4 major factors, optimized recipe and preparation process.
|
|
2013-05-23 12:28:18
正在翻譯,請(qǐng)等待...
|
湖北省互聯(lián)網(wǎng)違法和不良信息舉報(bào)平臺(tái) | 網(wǎng)上有害信息舉報(bào)專區(qū) | 電信詐騙舉報(bào)專區(qū) | 涉歷史虛無主義有害信息舉報(bào)專區(qū) | 涉企侵權(quán)舉報(bào)專區(qū)